Results 1 to 10 of about 3,418 (68)

Methylglyoxal Affects Dopamine Homeostasis in SH-SY5Y Cells Through the Modulation of miR-190a and miR-214. [PDF]

FASEB J
In SH‐SY5Y cells, Methylglyoxal (MGO) reduces the intracellular dopamine content, up‐regulating the expression of proteins that modulate dopamine amount (MAO‐B, COMT, and α‐Syn). The MGO‐induced increase of COMT and α‐Syn expression is mediated by the reduction of miR‐214 and miR‐190a levels.
Croce A, Mirra P, Pignalosa FC, Zatterale F, Prevenzano I, Conza D, Ulianich L, Miele C, Beguinot F, Fiory F.   +9 more
europepmc   +2 more sources

Loss of β-catenin in cholangiocytes promotes hepatocyte reprogramming and vascular remodeling during murine cholestasis. [PDF]

Cell Commun Signal
Carson M, Fornsaglio J, Case Iv R, Aggarwal R, Meadows V, Kim CK, Molina L, Cornuet P, Liu JJ, Liu S, Nejak-Bowen K.   +10 more
europepmc   +1 more source

A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders. [PDF]

Nat Med
Bolsewig K, Bellomo G, Hok-A-Hin YS, Al Idrissi I, Vermunt L, Lleó A, Alcolea D, Sieben A, Engelborghs S, Simonsen AH, Hasselbalch SG, Bech S, Morrema THJ, Hoozemans JJM, Bol JGJM, van Alphen J, Gaetani L, Chiasserini D, Paolini Paoletti F, Parnetti L, Kang S, Lee YG, Jeon S, Lee A, Jeon S, Ye BS, Del Campo Milán M, van der Flier WM, van de Berg WDJ, Lemstra AW, Willemse EAJ, Teunissen CE.   +31 more
europepmc   +1 more source

Fuzheng Huayu formula ameliorates chronic cholestatic liver injury by upregulating PPARa in mice. [PDF]

Chin Med
Zhang Z, Tang EQ, Li CH, Wang BB, Liang Y, Lv JX, Chen GF, Liu W, Mu YP, Liu P, Chen JM.   +10 more
europepmc   +1 more source

Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma. [PDF]

Cancer Med
Inoue M, Ogasawara S, Asahara K, Sato R, Watanabe S, Anzai H, Tsubura K, Watabe T, Fujiya M, Akatsuka T, Izai R, Katayama K, Sawada M, Tsuchiya T, Miwa C, Yoshino R, Yonemoto T, Fujimoto K, Unozawa H, Yumita S, Kanzaki H, Koroki K, Kobayashi K, Nakamura M, Kanogawa N, Nakamoto S, Yokoyama M, Kato J, Moriguchi M, Aramaki T, Morimoto N.   +30 more
europepmc   +1 more source

Prediction of lymph node metastasis in non-small cell lung cancer and its correlation with Ki-67 expression: a comparative study between intravoxel incoherent motion imaging and ¹⁸F-FDG PET. [PDF]

BMC Med Imaging
Wei W, Chen Q, Meng N, Wang X, Liu Y, Zhang J, Wu Y, Pan J, Huang Z, Yang Y, Wang Z, Liu Q, Fu F, Wang M.   +13 more
europepmc   +1 more source

STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer. [PDF]

Signal Transduct Target Ther
Chibaudel B, Dourthe LM, André T, Henriques J, Bourgeois V, Etienne PL, Desramé J, Carola E, Dupuis O, Baba-Hamed N, Auby D, Louvet C, Maillard E, Romano O, Tournigand C, Garcia-Larnicol ML, Shacham-Shmueli E, Bird BH, Ghiringhelli F, de Gramont A.   +19 more
europepmc   +1 more source

Mesenchymal stromal cell administration promotes macrophage-mediated bile duct regeneration. [PDF]

Regen Ther
Igarashi T, Kimura N, Abe H, Yoshida T, Watanabe Y, Kamimura H, Sakamaki A, Yokoo T, Kamimura K, Tsuchiya A, Terai S.   +10 more
europepmc   +1 more source

Dietary Lauric Acid Suppresses Inflammation, Cholestasis, Hepatocyte Injury, and Senescence in 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine-induced Inflammatory Cholangiopathy. [PDF]

Cell Mol Gastroenterol Hepatol
Ghosh S, Devereaux MW, Anderson AL, Anderson CC, D'Alessandro A, Orlicky DJ, Sokol RJ.   +6 more
europepmc   +1 more source

Contemporary Antiretroviral Therapy Regimens in People With HIV Who Initiated Treatment in the Pre-Antiretroviral Therapy Era. [PDF]

J Med Virol
Adachi E, Okuno S, Kanno Y, Koga M, Yotsuyanagi H.   +4 more
europepmc   +1 more source